等待开盘 10-17 09:00:00
+0.030
+1.60%
Ernexa Therapeutics (NASDAQ: ERNA) will present at the Cell & Gene Meeting on the Mesa on October 7, 2025, in Phoenix, Arizona, and virtually. The company will highlight its progress in developing iMSC-based therapies for advanced cancer and autoimmune diseases. Ernexa's pipeline includes ERNA-101 for ovarian cancer and ERNA-201 for autoimmune diseases, both utilizing its synthetic, allogeneic iMSC technology. The presentation will showcase Ernex...
10-01 12:30
<p>Ernexa Therapeutics (NASDAQ: ERNA), a company developing innovative stem cell therapies for treating advanced cancer and autoimmune diseases, announced that its CEO, Sanjeev Luther, will participate in a panel discussion at the 5th Annual iPSC Drug Development Summit on October 1 in Boston. The company is advancing a best-in-class approach using engineered induced mesenchymal stem cells (iMSC) derived from induced pluripotent stem cells (iPSC)...
09-29 12:30
Ai快讯财联社9月19日消息,利弗莫尔证券数据披露了今日港股新股相关资讯。 紫金黄金国际 1. 招股信息:2025年9月19日至9月24日进行招股...
09-19 10:45
①紫金黄金国际和西普尼今起招股,入场费是多少?保荐人、基石投资者是什么机构? ②哪些公司近期通过了港交所上市聆讯?
09-19 10:11
依波路(01856.HK)发布公告,预期集团于截至2025年6月30日止六个月将取得约2180万港元的净亏损,相较于2024年同期约530万港元的净亏损有所扩大。
08-22 21:30
证券之星消息,截至2025年7月28日收盘,依波路(01856.HK)报收于1.28港元,与上一交易日持平,成交量22.8万股,成交额29.42万港元。
07-28 17:49
香港联交所最新资料显示,7月9日,Full Day Limited增持依波路(01856.HK)220万股,每股作价1港元,总金额为220万港元。增持后最新持股数目约为2.20亿股,最新持股比例为61.02%。。
07-11 20:50